Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer.

This important study reveals a critical role of the transcription factor NR2F2 in mouse fetal Leydig cell (FLC) differentiation. With elegantly carried out experiments, the authors provide compelling ...

Patients with liver tumors that meet the following may be candidates: The tumor is less than 4 centimeters in size Have three or fewer tumors The tumor is in a favorable location for treatment Talk to ...

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Ovarian Cancer.

Tumors are the result of abnormal cell growth. Usually, the cells in your body grow and divide to form new cells whenever your body needs them. When older cells die, they’re replaced by new ones.

We work right across the cancer research pathway with strengths ranging from cell biology to healthcare research. We aim to nurture the thought leaders of today and tomorrow through the provision of ...

To address this gap, researchers analyzed gene expression within individual tumor cells. This study reports the molecular features and interactions of tumor and immune cells associated with two ...

Surgery and chemotherapy are the primary therapies for OC; however, patients often experience recurrence. Given the intimate interaction between OC cells and the tumor microenvironment (TME), it is ...

In a study published in Nature Communications, Lewis Zhichang Shi, M.D., Ph.D., and University of Alabama at Birmingham colleagues show, for the first time, how HIF1α in T cells is key for ...